This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lo Muzio, L. Articles by Altieri, D.C. Search for Related Content PubMed PubMed Citation Articles by Lo Muzio, L. Articles by Altieri, D.C. Pubmed/NCBI databases Medline Plus Health Information Oral Cancer Social Bookmarking                         What's this?

Survivin, a Potential Early Predictor of Tumor Progression in the Oral Mucosa

¹ Institute of Dental Sciences, Faculty of Medicine, University of Ancona, Ancona, Italy;
² Department of Biomorphological and Functional Sciences, Pathology Unit, Faculty of Medicine, University of Naples Federico II, Naples, Italy;
³ Institute of Dental Sciences, University of Catania, Catania, Italy;
⁴ Department of Dental Sciences and Maxillofacial Surgery, Faculty of Medicine, University of Naples Federico II, Naples, Italy;
⁵ Department of Oral Pathology, Faculty of Dentistry, Hiroshima University, Hiroshima, Japan; and
⁶ Department of Cancer & Biology and the Cancer Center, Medical School, University of Massachusetts, Worcester, USA;

Correspondence: ^* corresponding author, Via Carelli 28, 71100 Foggia, Italy, lomuziol{at}tin.it or llomuzio{at}tin.it

Survivin is a recently described apoptosis inhibitor selectively over-expressed in most tumors. Immunohistochemistry was used to investigate a potential role of survivin as an early predictor of malignant transformation in precancerous and cancerous lesions of the oral cavity. Survivin was present in 10/30 cases (33%) of oral precancerous lesions without malignant progression, and in 15/16 cases (94%) of oral precancerous lesions evolved into full-blown squamous cell carcinoma. Tumors that progressed from these precancerous lesions retained widespread survivin positivity (100%). Variations among group means were highly statistically significant (p < 0.001). No significant correlation was found between survivin expression and the degree of dysplasia. High expression of cytoplasmic/nuclear survivin is an early event during oral carcinogenesis and may provide a useful tool for the identification of precancerous lesions at higher risk of progression into invasive carcinoma.

Key Words: survivin • precancerous lesion • IAP • oral squamous cell carcinoma • apoptosis

Journal of Dental Research, Vol. 82, No. 11, 923-928 (2003)
DOI: 10.1177/154405910308201115


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				O. Kujan, R. Oliver, L. Roz, G. Sozzi, N. Ribeiro, R. Woodwards, N. Thakker, and P. Sloan Fragile Histidine Triad Expression in Oral Squamous Cell Carcinoma and Precursor Lesions. Clin. Cancer Res., November 15, 2006; 12(22): 6723 - 6729. [Abstract] [Full Text] [PDF]

				A. D. Schimmer Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice Cancer Res., October 15, 2004; 64(20): 7183 - 7190. [Abstract] [Full Text] [PDF]